Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

05 Jul, 2018, 22:05 BST JHL Biotech Announces China Approves Clinical Trial Rituximab Biosimilar to Treat Non-Hodgkin Lymphoma

JHL Biotech announced today that the Center for Drug Evaluation (CDE), State Drug Administration of China (SDA) has approved JHL's Phase I and...


05 Jul, 2018, 12:43 BST Sagentia Receives Confirmation of Registration to ISO 13485:2016

Sagentia, a Science Group company, announces that it is now registered to ISO 13485:2016, receiving confirmation of the transition nearly a year...


05 Jul, 2018, 11:00 BST Jennewein Biotechnologie to Build New R&D Centre for Synthetic Organisms and Microbiome Research in Bonn, Germany

Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn...


04 Jul, 2018, 08:00 BST Forendo Pharma Initiates Phase I Study for Potential New, Targeted Treatment for Endometriosis

Forendo Pharma, a drug development company focusing on novel oral treatments for endometriosis patients, today announces it has received clinical...


03 Jul, 2018, 12:00 BST Get Ready for the Summer With Astaxanthin From Algatech

New clinical study supports astaxanthin supplementation for protecting skin from damage associated with sun exposure A new randomized,...


03 Jul, 2018, 08:00 BST UK’s NICE Publishes a Medtech Innovation Briefing on PICO™ for the Prophylactic Use in Surgically Closed Incisions to Reduce Surgical Site Complications

Smith & Nephew (LSE: SN) (NYSE: SNN), the global medical technology business, announces that the UK's National Institute for Health and Care...


02 Jul, 2018, 13:00 BST ESHRE 2018: GEDEON RICHTER Announces the Winners of the FORWARD Initiative - a Fertility Research Grant Dedicated to Innovative Reproductive Research

Today, GEDEON RICHTER announced the 6 winners of its 2018 FORWARD Grant initiative - a highly-competitive, fertility research grant that is...


29 Jun, 2018, 13:15 BST Vyxeos™ Receives Positive CHMP Opinion for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP)...


29 Jun, 2018, 00:01 BST Results From Pivotal Phase 3 PROSPER Trial of XTANDI[TM] (enzalutamide) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Published in New England Journal of Medicine

Results show enzalutamide plus androgen deprivation therapy significantly reduced the risk of developing metastases or death by 71 percent...


28 Jun, 2018, 17:08 BST Elsevier: Preprints With The Lancet Launches on SSRN

SSRN, Elsevier's world leading preprint server and early stage research platform, has today announced the launch of 'Preprints with The Lancet' -...


26 Jun, 2018, 14:13 BST Cantargia Announces Pre-clinical Results Showing Positive Effects of CAN04 Combined With Approved Cancer Therapies

Cantargia AB today announces pre-clinical results from a study combining the antibody CAN04 (nidanilimab) and chemotherapy. In in vivo based models...


26 Jun, 2018, 13:05 BST BrainStorm Provides Update on "Right to Try" Policy

Webcast and Conference Call at 8:30am Eastern Time Today BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem...


26 Jun, 2018, 07:31 BST Selective AXL Inhibitor Bemcentinib Meets Pre-specified Efficacy Endpoint in Stage 1 of NSCLC Phase II Combination Trial With KEYTRUDA®

BerGenBio ASA (OSE:BGBIO) announces today that on a top-line, preliminary basis, the first efficacy endpoint has been met in its Phase II clinical...


25 Jun, 2018, 14:28 BST Theragnostics Announces First Patient Enrolled in Their Prospective Phase II Study of 68Ga-THP-PSMA in Prostate Cancer

Theragnostics Ltd is a global company dedicated to developing radiopharmaceuticals for cancer patients. Today they announce the enrolment of their...


25 Jun, 2018, 13:00 BST WCG (WIRB-Copernicus Group) Clinical Services Division Partners with InformedDNA to Help Sponsors Design and Execute More Effective Clinical Trials

Companies join forces to deliver new solutions that optimize genetics in clinical trials in the era of precision medicine WCG®...


23 Jun, 2018, 15:12 BST Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study

Adults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in HbA1c and a 30% lower rate of...


23 Jun, 2018, 15:09 BST Ozempic® Provided Greater Weight Reductions for Adults With a Baseline BMI ≥25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis

Poster Presentation #1083-P Ozempic® (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg,...


23 Jun, 2018, 15:06 BST Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in...


23 Jun, 2018, 13:05 BST Significant Blood Sugar Improvement With Xultophy® Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications

Oral Presentation #127-OR Adults with type 2 diabetes treated with Xultophy® (insulin degludec and liraglutide injection) also experienced no...


22 Jun, 2018, 10:00 BST APAC Biotech and Diakonos Sign Technology Transfer and Licensing Agreement to Bring New Immunotherapy Technology to India

India-Based APAC Biotech and US-Based Diakonos Research sign a first-of-its-kind technology transfer and licensing agreement to bring new...


22 Jun, 2018, 07:00 BST NICE Recommends Sanofi's New Treatment Dupixent® ▼ (dupilumab) for Adults with Moderate to Severe Atopic Dermatitis in England[1]

- Positive recommendation for Dupixent® (dupilumab) in Final Appraisal Determination (FAD) paves the way for the first targeted biologic...


22 Jun, 2018, 03:00 BST APAC Biotech and Diakonos Sign Technology Transfer and Licensing Agreement to Bring New Immunotherapy Technology to India

India-Based APAC Biotech and US-Based Diakonos Research sign a first-of-its-kind technology transfer and licensing agreement to bring new...


21 Jun, 2018, 16:04 BST Nordic Nanovector Announces First Patient Dosed in Pivotal PARADIGME Trial of Betalutin® in Third-line Follicular Lymphoma Patients

Nordic Nanovector ASA (OSE: NANO) announces that the first patient has been dosed in its pivotal PARADIGME Phase 2b trial with Betalutin®...


21 Jun, 2018, 10:00 BST Grünenthal, Lead Discovery Center and Max Planck Society Enter Into a Research Collaboration on Charcot-Marie-Tooth 1A (CMT1A)

Grünenthal, Lead Discovery Center GmbH (LDC), Max-Planck Innovation and Max Planck Institute of Experimental Medicine (MPI-EM) have entered into a...


Most Viewed Clinical Trials & Medical Discoveries